Term ended May 6, 2024 · High confidence
20-year base term ended May 6, 2024
USPTO later recorded it as expired for non-payment on Sep 7, 2026.
May 6, 2004
May 6, 2024
Aug 2, 2022
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 6, 2004, when application 10/841,250, the earliest non-provisional in its chain, was filed (this one was filed Mar 21, 2017) | May 6, 2024 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,348,004, US 7,381,408, US 7,404,956, US 7,820,162) | resolves to May 6, 2024, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | No maintenance fee can end the term early | term ended | High confidence |
| USPTO status record | Recorded as expired for non-payment on Sep 7, 2026, after the term ended | no change | High confidence |
| Computed term end | The steps above, in order | May 6, 2024 | High confidence |
This family
| US 7,404,956 | In force Jun 2028 | Jun 2028 |
| US 7,348,004 | In force Mar 2028 | Mar 2028 |
| Application PCT/US2006/000140 | PCT application no patent term | no patent term |
| US 7,862,820 | Term ended no later than Mar 2026 | no later than Mar 2026 |
| US 8,329,182 | Term ended no later than May 2024 | no later than May 2024 |
| US 8,932,830 | Term ended May 2024 | May 2024 |
| US 9,636,416 | Term ended May 2024 | May 2024 |
| US 11,401,322 | this patent May 2024 | May 2024 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 31, 2018 Reel 46767, frame 154 | Peters, Robert T.; Mezo, Adam R.; Rivera, Daniel S.; Bitonti, Alan J.; Low, Susan C. | Syntonix Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Aug 31, 2018 Reel 46995, frame 152 | Syntonix Pharmaceuticals, Inc. | Biogen Idec Hemophilia Inc. | Change of Name |
| Aug 31, 2018 Reel 46995, frame 602 | Biogen Hemophilia Inc. | Bioverativ Therapeutics Inc. | Change of Name |
| Aug 31, 2018 Reel 46995, frame 632 | Biogen Idec Hemophilia Inc. | Biogen Hemophilia Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
A terminal disclaimer resolved from the filed document, referencing US 7,348,004, US 7,381,408, US 7,404,956, US 7,820,162, ends no earlier than this term, so it caps nothing.